| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/09/2006 | CA2575675A1 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
| 03/08/2006 | EP1632778A2 Natural ligand of gpcr chemr23 and uses thereof |
| 03/08/2006 | EP1632574A1 Fibroblast growth factor homologs |
| 03/08/2006 | EP1632571A1 Human artificial chromosome containing human antibody Lambda light chain and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 03/08/2006 | EP1632502A1 Methods of detecting collagen degradation in vivo |
| 03/08/2006 | EP1632500A2 A lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
| 03/08/2006 | EP1632499A2 Gene sequences amplified in tumours and their diagnostic uses |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/08/2006 | EP1631591A2 Connective tissue growth factor antibodies |
| 03/08/2006 | EP1631590A2 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 03/08/2006 | EP1631588A2 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 03/08/2006 | EP1631315A2 Antibodies which bind human cxcr3 |
| 03/08/2006 | EP1631314A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 03/08/2006 | EP1631313A2 Combination therapy for b cell disorders |
| 03/08/2006 | EP1631312A2 Compositions and methods for the therapy of inflammatory bowel disease |
| 03/08/2006 | EP1631311A2 Humanized anti-ccr2 antibodies and methods of use |
| 03/08/2006 | EP1631238A2 Antibodies specific for cancer associated antigen sm5-1 and uses thereof |
| 03/08/2006 | EP1631236A2 Cell surface protein associated with human chronic lymphocytic leukemia |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1265990B1 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1032662B1 Methods and compositions for immunomodulation |
| 03/08/2006 | EP0983303B1 Method for the production of non-immunogenic proteins |
| 03/08/2006 | EP0975971B1 Methods for detecting cell apoptosis |
| 03/08/2006 | EP0941332B1 Carrot antifreeze polypeptides |
| 03/08/2006 | EP0920502B1 Methods and means for modifying complement activation |
| 03/08/2006 | EP0907312B1 Compositions and methods for taxol biosynthesis |
| 03/08/2006 | EP0861894B1 Differentiation-suppressive polypeptide |
| 03/08/2006 | EP0777734B1 New polypetides having a toxic activity against insects of the dipter family |
| 03/08/2006 | EP0755406B1 Method and product for regulating cell responsiveness to external signals |
| 03/08/2006 | CN1745299A Method of diagnosis, treatment and useful agents for conditions characterized by modulation in the level of activin beta c |
| 03/08/2006 | CN1745298A Method of assaying elastin digestion product and assay kit, method of detecting aortic wall interlayer and detection reagent |
| 03/08/2006 | CN1745175A Active immunization to generate antibodies to soluble A-beta |
| 03/08/2006 | CN1745104A Antibodies specific for plasmacytoid dendritic cells |
| 03/08/2006 | CN1745103A Antibody molecules having specificity for human IL-1 beta |
| 03/08/2006 | CN1745102A Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 03/08/2006 | CN1745101A Antibodies directed to tumor necrosis factor and uses thereof |
| 03/08/2006 | CN1745097A Tumour tag and its use |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1743456A Modulators of the function of receptors of the TNF/NGF receptor family and other protein |
| 03/08/2006 | CN1743452A Phosphokinase and its use |
| 03/08/2006 | CN1244701C Cellulases, genes encoding them and uses thereof |
| 03/08/2006 | CN1244595C Tumor suppressor protein and its application |
| 03/07/2006 | US7009043 isolated from xenopus egg extracts; adenosine triphosphatases; mitosis |
| 03/07/2006 | US7009040 Administering a monoclonal antibody encoded by a clone on deposit which binds specifically to an antigen expressed by a tumor; screening for cancerous cells; biological conjugation with a radioisotope, enzyme toxins and hematogenous cells; antitumor agents; anticarcinogenic agents; cytotoxicity |
| 03/07/2006 | US7009037 Modified HIV-1gag p17 peptide and immunogenic composition |
| 03/07/2006 | US7008942 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008775 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion |
| 03/07/2006 | US7008773 Method for identifying active anti apoptosis compounds |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008625 Recombinant constructs of Borrelia burgdorferi |
| 03/07/2006 | US7008624 IL-15 or muteins covalently bound to group (PEG, PVP,PVA, dextran, gelatin) that sterically interferes with signal transduction through IL-15 receptor complex; allograft rejection and graft-versus-host disease |
| 03/07/2006 | US7008623 Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/02/2006 | WO2006023420A2 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | WO2006023403A2 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | WO2006022882A2 Canine pancreatic lipse |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006021874A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/02/2006 | WO2006021210A2 Binding member towards pneumolysin |
| 03/02/2006 | WO2006012500A9 Crystallization of antibodies or fragments thereof |
| 03/02/2006 | WO2005123777A3 Method of treating granuloma annulare or sarcoid |
| 03/02/2006 | WO2005105133A3 Methods and compositions for preserving the viability of photoreceptor cells |
| 03/02/2006 | WO2005095964A3 Methods and compositions for the detection of cervical disease |
| 03/02/2006 | WO2005090404A3 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 03/02/2006 | WO2005089093A3 Improved expression systems with sec-system secretion |
| 03/02/2006 | WO2005087802A3 Process for producing polypeptides |
| 03/02/2006 | WO2005079243A3 Compositions and methods for identifying sperm for forensic applications |
| 03/02/2006 | WO2005072388A3 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 03/02/2006 | WO2005068622A3 Mixtures of binding proteins |
| 03/02/2006 | WO2005026375A3 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/02/2006 | WO2005026326A3 Generation of chicken cell lines from embryonic stem cells and germ cells |
| 03/02/2006 | WO2005000351A3 Combination therapy for b cell disorders |
| 03/02/2006 | WO2004092332A3 Sars virus polypeptides |
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060047107 Cortistatin: neuropeptides, compositions and methods |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060045879 Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use |
| 03/02/2006 | US20060045878 Pancreas-derived plasminogen activator inhibitor |
| 03/02/2006 | US20060045877 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 03/02/2006 | US20060045876 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 03/02/2006 | DE19856777B4 Anti-Petasin-Antikörper, Verfahren zu ihrer Herstellung und ihre Verwendung Anti-petasin antibodies, processes for their preparation and their use |
| 03/02/2006 | DE102005026163A1 Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung Against the Marburg I polymorphism of the factor VII-activating protease (FSAP) Antibodies, their production and use |
| 03/02/2006 | CA2578361A1 Binding member towards pneumolysin |
| 03/02/2006 | CA2577631A1 Methods and compositions for treating allergic inflammation |
| 03/02/2006 | CA2577370A1 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | CA2577329A1 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | CA2577188A1 Extended treatment of multiple sclerosis |
| 03/02/2006 | CA2576925A1 Method of delivering rna interference and uses thereof |
| 03/02/2006 | CA2576500A1 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 03/02/2006 | CA2563507A1 Canine pancreatic lipase |
| 03/02/2006 | CA2554707A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |